Cuprior

trientine · Orphalan
AUTHORISED IN THE EU

What Cuprior is used for

Cuprior is indicated for the treatment of Wilson's disease in adults, adolescents and children ≥ 5 years intolerant to D-penicillamine therapy.

Approved use, as published by the European Medicines Agency.

Key facts

Brand
Cuprior
Active substance
trientine
Disease area
Hepatolenticular Degeneration
Medicine group
Other alimentary tract and metabolism products
ATC code
A16AX
Marketing authorisation holder
Orphalan
Authorised in the EU since
2017

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Cuprior used for?

Cuprior is indicated for the treatment of Wilson's disease in adults, adolescents and children ≥ 5 years intolerant to D-penicillamine therapy.

What is the active substance in Cuprior?

Cuprior contains trientine.

Who makes Cuprior?

The EU marketing authorisation holder is Orphalan.

Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, EU

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.